<DOC>
	<DOCNO>NCT01791556</DOCNO>
	<brief_summary>The study fund Office Global AIDS Coordinator ( OGAC # KE-07-0044 ) . The purpose study two-fold . The first purpose see routine monitoring level HIV virus blood ( viral load ) every six month superior monitor standard clinical evaluation immune status ( CD4 count ) intermittent viral load monitoring adult receive antiretroviral therapy ( ART ) . The second purpose understand cost implication possible benefit routine HIV viral load monitoring .</brief_summary>
	<brief_title>Clinic-based ART Diagnostic Evaluation</brief_title>
	<detailed_description>The Kenya Ministry Health ( MoH ) guideline antiretroviral therapy ( ART ) manual ART provider recommend targeted viral load monitor ART management . While limited use viral load monitoring exist due limitation technical financial resource , feasibility cost-effectiveness viral load monitoring prospectively studied ART roll-out clinic level . `` Clinic-based ART Diagnostic Evaluation '' ( CLADE ) unblinded , randomize ( 1:1 ) , prospective , observational , cohort public health evaluation ( PHE ) aim evaluate superiority cost-effectiveness two recommend Ministry Health ART diagnostic evaluation approach clinic level adult treatment naive patient begin Ministry Health approve first-line ART : `` routine care '' , common approach ART roll-out clinical ( World Health Organization ) stag immunological ( CD4 ) monitoring primary baseline follow-up evaluation target viral load monitoring ; `` viral load care '' , routine viral load include clinical immunological evaluation . In study plan enroll 820 adult participant start ART , 410 people enrol public health evaluation arm . Arm A/ `` routine care '' receive MoH standard care monitor consist baseline CD4 WHO stag every 6 month , clinically indicate , CD4 WHO stag criterion guide care treatment addition routine clinical evaluation . In addition , MoH criterion target viral load monitoring use . Arm B/ `` viral load guide care '' receive MoH standard care Arm A also routine viral load monitoring baseline every 6 month , clinically indicate , guide care treatment . Each arm receive Kenya Ministry Health first-line ART . Participants meet MoH criterion treatment failure second-line ART .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>RNA Virus Infections</mesh_term>
	<criteria>Male female &gt; 18 year age time consent . Identified clinic staff intend start ART next clinic visit Provision inform consent either Kiswahili , Luo English Any reason ( medical , physical location home relative clinic , ) exist ART team feel prohibit volunteer come routine ART clinic visit . Any reason ( medical , social , ) exist ART team study team feel may present risk participant outweigh benefit participate study . Pregnancy ( confirm suspect ) time enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Kenya</keyword>
	<keyword>viral load</keyword>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>randomize clinical trial</keyword>
	<keyword>ART monitoring</keyword>
	<keyword>treatment failure</keyword>
	<keyword>HIV resistance</keyword>
</DOC>